BioElectronics, a Frederick, MD, company that makes anti-inflammatory patches, signed a deal last week with Eximeq for the Mexican healthcare-services provider to distribute BioElectronics’ ActiPatch south of the border. ActiPatch delivers pulsed electromagnetic frequency (PEMF) to accelerate healing of soft tissue injuries. PEMF has been shown to reduce pain and swelling by lessening the body’s inflammatory response. ActiPatch is FDA cleared for the treatment of edema following blepharoplasty.
BioElectronics has been busy lately ramping up sales and marketing activity. Prior to announcing the Eximeq deal, the company secured distribution agreements with partners in New York, Philadelphia and Canada.